chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Administered HPV, MCV vaccine to patient at approx 0920.  While patient was in waiting area, she requested Hep A vaccine.  After administering Hep A vaccine, while patient was again in waiting area, within 5 min. Supervisor and I were called to assist patient to supine position as patient presented with cyanosis of lips, pallor and diaphoresis.  Pt also complained of weakness and vision being diminished.  Assisted patient to supine position with feet elevated.  Pt noted with weakness, cyanosis of the lips, pallor and diaphoresis.  Pt remianed in supine position for approx 15 min.  Pt then slowly raised herself to a sitting position for approx 5 min and was given a lollypop, some ice chips and cold water.  Upon drinking water, pt then proceeded to waiting area.  After in waiting area for approx 7 min, pt became diaphoretic again and stated "can I lay down again?"  Pt assisted to supine position on table in exam rm with feet elevated.  Pt remained in supine position for approx 10 min., then assisted to sitting position.  Pt again, drank another cup of cold water and proceeded to waiting area.  After remaining in waiting area for approx 30 min, pt again complained of feeling shaky.  Pt's nailbeds were cyanotic and pt upper and lower extremities were noted to be shaky.  Pt was also still presenting with diaphoresis.  B/P noted as 92/70.  Notifed ER and assisted pt to ER via wheelchair.  Pt's mother at side.  Also, advised pt and mother that patient should not drive her vehicle but should have mother drive her to destination.
Uritcaria; No post hx of allergy; 4th dose of DTP;
Hospitalization: 9/3/22 ADMITTED, 9/6/22 DISCHARGED. Presentation to the ED: 2 week history of mid back pain and right upper quadrant abdominal pain. COVID-19 + date: 9/3/22. Treatment: Completed course of oral doxycycline.  Discharge to: HOME.
caused me a lot of grief in speaking; this has been brutal; contracted Bell's Palsy; face was deformed; This spontaneous case was reported by a consumer and describes the occurrence of BELL'S PALSY (contracted Bell's Palsy), DEFORMITY (face was deformed), GRIEF REACTION (caused me a lot of grief in speaking) and FEELING ABNORMAL (this has been brutal) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced BELL'S PALSY (contracted Bell's Palsy) (seriousness criteria disability and medically significant). 22-Mar-2021, the patient experienced DEFORMITY (face was deformed) (seriousness criterion medically significant). On an unknown date, the patient experienced GRIEF REACTION (caused me a lot of grief in speaking) (seriousness criterion medically significant) and FEELING ABNORMAL (this has been brutal) (seriousness criterion medically significant). At the time of the report, BELL'S PALSY (contracted Bell's Palsy), DEFORMITY (face was deformed), GRIEF REACTION (caused me a lot of grief in speaking) and FEELING ABNORMAL (this has been brutal) outcome was unknown.            Concomitant medication were not reported. Treatment medication were not reported.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Diminished taste; Diminished smell; A spontaneous report was received from a physician concerning a 67-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and who experienced diminished taste and smell.   The patient's medical history included an ongoing respiratory issue causing a cough. Concomitant product use was not provided by the reporter   On 23-Dec-2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   On 24-Dec-2020, one day after receiving his injection, patient experienced diminished taste and smell but by 25-Dec-2020, he was back to baseline.  A negative Covid test was conducted on an undisclosed date.  Additionally, the patient reported that he has a chronic cough related to an ongoing respiratory issue.   Treatment information was not provided.  Patient was advised to consult his physician.   Action taken with mRNA-1273 in response to the events was not provided.  The events diminished taste and smell were resolved.; Reporter's Comments: This case concerns a 67-year-old male, patient, who experienced  unexpected non-serious events of diminished taste and smell. The events occurred approximately one day after receiving first dose of mRNA-1273, (lot # unknown). Treatment information was not provided. Based on the current available information and temporal association between the use of the product and onset of the events a causal relationship cannot be excluded and the events are considered possibly related to the vaccine.
Received by 1/29/03 4hrs after injection c/o increase temp 104.2, 12hours after injection c/o diarrhea/vomiting, very lethargic.  Symptoms continues for 24hours after injection, only given tylenol for fever, confort measures, no medical treatment
This spontaneous report was received form a nurse practitioner referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 10-SEP-2016, the patient was vaccinated with improperly stored dose of GARDASIL 9 (lot # M007764, expiry date: 30-JAN-2018 (strength, dose, route and anatomical location were not provide). Concomitant therapies were not provided. This is one of several reports received from the same reporter. Additional information has been requested.
Patient received 1st dose of Moderna Covid vaccine at age 17 yr 8 months. Returned on 4-1-21 for 2nd dose . No adverse symptoms reported after first dose. regional vaccine coalition contacted and instructed to proceed in giving 2nd dose.  nd dose Moderna vaccine given at age 17 yr 9 months.  Follow up with patient after 2nd dose.  Patient stated she feels fine.  Was  little achy after 2nd dose but did not treat with any medication and it resolved next day.  No side effects to report today (4-7-21)
3 HOURS AFTER GETTING VACCINE, I HAD BODYACHES, REDNESS, AND PAIN AT THE INJECTION SITE. THE FOLLOWING DAY (APPROX 16 HRS LATER), I HAD BACK PAIN, JOINT PAIN, HIGH FEVER OF 103.4F.
STINGING; BURNING/ TINGLING IN ENTIRE ARM; COULD FEEL THE CIRCULATION; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 12-MAR-2021, the subject experienced stinging. On 12-MAR-2021, the subject experienced burning/ tingling in entire arm. On 12-MAR-2021, the subject experienced could feel the circulation. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the stinging, burning/ tingling in entire arm and could feel the circulation was not reported. This report was non-serious.
The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from the practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 09-OCT-2017, the patient was vaccinated with a dose of GARDASIL 9 (strength and route were unknown) (lot# M040412 and expiration date 30-JUN-2019). On 20-FEB-2018, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (strength and route were unknown) (lot# N020352 and expiration date 10-APR-2020) for prophylaxis (Incorrect product storage). No adverse event was reported. The excursion temperature on 08-NOV-2017, 16-NOV-2017, 23-JAN-2018, 06-JUN-2018, 03-JUL-2018 and 14-AUG-2018 was 47 degree Celsius for maximize 15 hours. The excursion temperature on 07-DEC-2017 was 50 degree Celsius for maximize 8.75 hours. The call was not because of data logger. This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954:US-009507513-1810USA001955: US-009507513-1810USA001957: US-009507513-1810USA001958: US-009507513-1810USA001959: US-009507513-1809USA003709:
PT INSTRUCTED TO WAIT 30 MINUTES DUE TO SHE STATED AFTER THE FIRST DOSE, SHE HAD HEART RACING AFTER SHE GOT HOME, BUT QUIT AND HAD NO OTHER PROBLEMS. CHECKED ON PT AFTER 20 MIN(11:05AM), SHE WAS C/O ITCHY THROAT, THROAT TIGHTNESS WITH SWALLOWING, TONGUE NUMB, LIPS NUMB. PT WAS AWAKE, A&OX4, NO DISTRESS, RESPIRATIONS RATE NORMAL AND REGULAR, PULSE RATE NORMAL AND REGULAR. AT 11:05AM BEGAN MONITORING V/S, EVERY 5-15 MIN, SYMPTOMS PERSISTED, STAFF CALLED 911 AT 11:30AM, 11:32AM DOSE OF EPINEPHRINE INJECTABLE PEN 0.3MG GIVEN IM RVL, 11:40AM EMS ARRIVED. PT WALKED TO AMBULANCE AND TAKEN TO LOCAL HOSPITAL
I received my 2nd Pfizer vaccine on 04/01/2021. On May 7, 2021, I went to bed at 10 PM and woke up slightly before midnight.  When I woke up, I noticed that I could not see out of my right eye.  I went back to bed (and back to sleep).  When I got up the next morning, I realized that I still could not see.  My husband rushed me to the Eye Institute.  Immediately upon arrival, the emergency doctor, realized that I had an Eye Stroke (Blood Clot) in my right eye. I was then taken to a Full Service Hospital for testing and observation.  I was told from the very beginning that the vision would be irreversible.  I had no pain or any warnings prior to at the time of the event.
chills; fever; stomach issues; This case was reported by a consumer via call center representative and described the occurrence of chills in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th April 2019, the patient received the 1st dose of Shingrix. On 3rd May 2019, 4 days after receiving Shingrix, the patient experienced chills, fever and gastric disorder. On an unknown date, the outcome of the chills, fever and gastric disorder were unknown.   It was unknown if the reporter considered the chills, fever and gastric disorder to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced chills, fever and stomach issues and asked if it was possible to have these reactions after 4 days of vaccination.
Patient was given Moderna Bivalent dose of 0.2mL/10mcg instead of 0.25mL/25mcg because staff was not aware of update guidelines.  Communication that the 0.5mL/50mcg dose was authorized to give for 6mos-adult in a half dose based off CDC guidelines was not clear to physician and nursing staff.
Patient received 2nd dose too early per CDC Guidelines. Patient is aware and discussed with nurse. He will follow up to determine if he needs a second dose if severely immunocompromised.
1538- pt in vaccine observation area after receiving Moderna vaccine dose 2.  1539-Pt was minimally responsive and diaphoretic in her sit/walker. BP not reading , perhaps too low, pulse 70, R20,O2 sat 99% RA, No obvious sign of anaphylaxis. Family reported same symptoms previously, last on 3/12/21 and was eval in outside ED for syncope.  1540-Pt now less responsive but responds to simple commands, BP 63/45,P64,R16, O2sat 98% RA, cold compress applied to forehead.  1546- transferred to gurney in Trendelenburg &  decision made to call ambulance. 1550- 911 called.  Pt was transferred to ED
messenger RNA was found in breastmilk by women who took the vaccine afterwards; Lipid nanoparticles which exist for later than 2 days and stay in body fluids. They pass through placenta barriers as well; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (messenger RNA was found in breastmilk by women who took the vaccine afterwards) and IMMUNISATION REACTION (Lipid nanoparticles which exist for later than 2 days and stay in body fluids. They pass through placenta barriers as well) in a  patient of an unknown age and gender exposed to mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) , while the mother received the product for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the mother received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient was diagnosed with EXPOSURE VIA BREAST MILK (messenger RNA was found in breastmilk by women who took the vaccine afterwards) and IMMUNISATION REACTION (Lipid nanoparticles which exist for later than 2 days and stay in body fluids. They pass through placenta barriers as well). The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Delivered NOS. At the time of the report, EXPOSURE VIA BREAST MILK (messenger RNA was found in breastmilk by women who took the vaccine afterwards) had resolved and IMMUNISATION REACTION (Lipid nanoparticles which exist for later than 2 days and stay in body fluids. They pass through placenta barriers as well) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Transmammary), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.  Patient age was reported as 0 years.
I thought it was a very bad cold but after taking OTC medication it didn't get any better. I had a bad cough and lots of phlegm, I saw my doctor and tested for COVID but it was negative and I went home. After a few days I called again because it was getting worse and I was prescribed an antibiotic Cefuroxime Acetyl 250MG tablets I had to take twice a day for 10 days. I had an appointment with my pulmonologist and let him know the antibiotic wasn't working so he upped the dosage of the same medication as well as added steroids'. Afterwards I felt fine.
Contracted mild case of measles from vaccine- Dr. confirmed. High fever, loss of appetite, lethargy, loose stools, and rash; lasted 4-5 days.
There's a tiny bit of irritation in the outside corner of my left eye; eyelid is swollen; This is a spontaneous report from a contactable consumer (patient). A 66-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in the left arm on 29Jan2021 10:00 (lot number: EL9261) as single dose (at the age of 66-years-old) for covid-19 immunization, administered in public health department. Medical history included seasonal allergies. Concomitant medications included varicella zoster vaccine rge (cho) (SHINGRIX, GlaxoSmithKline) on 08Jan2021, lot number: GM2Y4, second dose in the left arm taken for immunization; rhodiola rosea (RHODIOLA) taken for an unspecified indication, start and stop date were not reported; loratadine (LORATADINE) taken for an unspecified indication, start and stop date were not reported; montelukast (MONTELUKAST) taken for an unspecified indication, start and stop date were not reported; fluticasone (FLUTICASONE) taken for an unspecified indication, start and stop date were not reported.  The patient previously took lanolin and experienced rash. The patient was not diagnosed with COVID-19 prior to vaccination. On 29Jan2021 at 22:00, the patient experienced a "tiny bit of irritation in the outside corner of my left eye and the eyelid was swollen". The patient has seasonal allergies, so this could be releted to that. Although, the patient has never had swollen eyelid issue before. The patient has not been tested for COVID-19 since the vaccination. The events were considered non-serious by the reporter. The event did not result in death, not life-threatening, did not require hospitalization, was not disabling and did not contribute to a congenital anomaly/birth defect. No treatment was received for the events. The patient has not recovered from the events.  Follow-up attempts are completed. No further information is expected.
tongue tingling, light headed, Benadryl given BP 142/78, P 85, R 12, Pulse Ox 100% Was able to drive to sisters house after recovery
right after the shots  about 15 minutes later i was dropping things on the floor and spilling things over. Then  At 9:00pm Feb.19, 2022 until 3:00am the next day within the time frame i was having a stomach ache, chills,muscle pains in my legs, nauseated and throwing up. hard to breathe sometimes i needed to raise the back of the bed to prop my head up for easy breathing. After throwing up many times i was able to fall asleep. now on Feb.20,2022 i feel much better just have a right side ache and runny nose now.
At time of vaccine, headache, watery eyes, fever, severe stomach cramps, pain in muschle and joints, blisters on lips, mouth and nose (symptomatic of actual anthrax). I was 8 weeks pregnant at time of vaccine. Severe unexplained liver and renal failure at 30 weeks gestation; emergency c-section live birth. Continued medical care; outcome unknown so far. A 60-day follow up report received 11/24/03 adds :Due to the fact that this may have complicated the pregnancy, resulting in HELLP syndrome, there may be long term liver and kidney damage. Additional pregnancy's are highly discouraged. Recovery still marked "Unknown". Change of name (divorce) noted. Sweats, stomach cramps, dizziness, aches in knees and hips. Later led to complications in pregnancy causing HELLP syndrome (renal failure, liver damage, high blood pressure). Discharge summary states pre-eclamsia, ileus, renal failure, edema. msv
* Extreme headache, extreme nausea, vomiting, tiredness * Benedryl and Tylenol * Three days
The day after vaccination  development of abdominal cramping, urgency, repeated episodes of diarrhea. Some nausea, no vomiting.  Abdominal cramping still episodic 3 days later.  No fever.
LEFT UPPER EXTREMITY INFLAMMATORY IMMUNIZATION REACTION TO PNEUMOVAX OR PREVNAR, FEVER, POSSIBLE EARLY CELLULITIS, GIVEN KEFLEX 250/5 2 TSP. PO TID X 7 DAYS, PREDNISONE 10 MG 2 X 1 THEN 1 QD X 2, IBUPROFEN 400 Q 8 HOURS PRN.
This spontaneous report was received from a pharmacist, referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 22-OCT-2015, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB (Lot# L016427; expiration date: 13-APR-2017) (dose and route of administration were not provided). Concomitant therapies were not reported. No adverse effects reported. The pharmacist explained that the RECOMBIVAX HB doses were not involved in a previous temperature excursion and this time the temperature and time frame were: 1.4C for 22 hours 52 minutes and 8.6C for 112 hours and 5 minutes. This is one of several reports received from the same source (original report 1602USA004808). Additional information has been requested.
No adverse event. Person accidentally given 1ml dose. Monitored for 15 minutes without reaction.
States arm started getting sore that night. Was painful, red, and swollen to elbow next day 11/30/04 went to Dr. He reported to her had infection in arm. Something was dirty, tightly swollen to elbow. Started on Cephalex in 50mg tid x10days and Medrol Dose pack x 6 days. I talked to Dr's office and they did not say dirty, said possible cellulitis infection.
30JUN98 pt eval for 3cm lt thigh mass that mom reports appearing & enlarging over the preceding several weeks;showed a uniform mass suggestive of a solid density;aspiration of mass 10JUL98 produced thick, creamy blood-tinged material;
Symptoms 3/23 = coughing, back ache, leg discomfort, sore throat, congestion, fatigue. Mild to moderate + 3/24; Symptoms 3/23 = coughing, back ache, leg discomfort, sore throat, congestion, fatigue. Mild to moderate. Home AG + 3/24; This is a spontaneous report received from a contactable reporter(s) (Nurse).  A 38-year-old female patient (unknown if pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 as dose 4 (booster), sngle (Lot number: GJ6742) at the age of 38 years intramuscular, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), sngle (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 23Mar2023, outcome "recovering" and all described as "Symptoms 3/23 = coughing, back ache, leg discomfort, sore throat, congestion, fatigue. Mild to moderate.+ 3/24". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (24Mar2023) Positive. It was unknown if therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on temporal relationship.
Info has been received from a health professional concerning a female pt who in approximately Oct 2002 was vaccinated with a 1st dose of pneumococcal vaccine 23 polyvalent (Lot #643251/0445M). Additional therapy given at the same time, in the opposite arm, included a dose of influenza virus vaccine, "flu vaccine". Subsequently, in approx Oct 2002 and pt developed chills that night after receiving the vaccine, and small amount of soreness in both arms. The reporter requested a lot check. The records of testing prior to release of this lot have been checked by Compliance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. Unspecified medical attention was sought. Additional info has been requested.
SECOND DOSE OF THE GARDASIL, HPV VACCINE WAS ADMINISTERED ON 11/06/2012 AND ON 12/12/2012 WAS SEEN BACK IN THE DOCTORS OFFICE FOR DIZZINESS, NAUSEA, ABDOMINAL PAIN, FATIGUE, AND HEADACHES. DR ORDERED BLOOD WORK AND MONOSPOT, THESE SYMPTOMS HAS CONTINUED SINCE THIS DATE.
hypotonic-hyporesponsive episode occurred w/in 24hr of vax episode lasted approx 60min;
This spontaneous report was received from a physician concerning a female patient of unknown age. There was no pertinent medical history and no drug reactions or allergies. On 20-SEP-2000, the patient was vaccinated with a dose of VARIVAX (Merck) (lot number, expiry date, dose and route unspecified). There were no concomitant medications. On an unknown date, the patient developed chickenpox after receiving VARIVAX (Merck) and approximately on an unknown date in August 2013 (this past weekend), the patient was diagnosed with shingles. The patient was prescribed an unspecified antiviral approximately on an unknown date in August 2013 (this past weekend) after being diagnosed with shingles. It was unspecified if any lab tests were performed. The patient was not recovered from chickenpox and shingles. The relatedness for chickenpox and shingles was unknown for VARIVAX (Merck). Additional information has been requested.